Elasheer Osama M, Radi Shimaa M, Khalaf Mostafa S, Ghazally Mohamed H, Nigm Dalia A, Embaby Mostafa M
Pediatrics, Assiut University, Assiut, EGY.
Clinical Pathology, Assiut University, Assiut, EGY.
Cureus. 2024 Sep 26;16(9):e70251. doi: 10.7759/cureus.70251. eCollection 2024 Sep.
The most common inherited illness, thalassemia, is thought to have a detrimental effect on public health, particularly in endemic areas. Children with beta thalassemia disease have several mutations. Prevention and premarital examination are still the most effective measures to lessen the burden of beta thalassemia.
This study primarily aimed to determine the beta thalassemia carriers in relatives of beta thalassemia major children, the role of gene study in the confirmation of beta thalassemia trait diagnosis, and to detect the genetic defect in the relatives of beta thalassemia major children.
The cross-sectional study was conducted on 109 healthy children, aged between six months and 18 years, who were the relatives (second and fourth degree) of beta thalassemia major cases.
Gene screening, using the amplification refractory mutation system (ARMS) polymerase chain reaction (PCR), covered the most common 22 alleles in the Mediterranean region, and was successful in detecting 61.5% of beta-globin chain mutations of studied participants, in addition to high prevalence (34.8%) of beta thalassemia carriers among the relatives of beta thalassemia children.
The beta thalassemia carrier rate was found to be highly prevalent among relatives of beta thalassemia major children. Despite the accuracy of gene screening in the detection of beta thalassemia carriers, the use of the most common 22 alleles can only detect 61.5% of carriers; hence, the value of tested gene study is still limited in the detection of carrier rates.
地中海贫血是最常见的遗传性疾病,被认为对公众健康有不利影响,尤其是在流行地区。重型β地中海贫血患儿存在多种突变。预防和婚前检查仍然是减轻β地中海贫血负担的最有效措施。
本研究主要旨在确定重型β地中海贫血患儿亲属中的β地中海贫血携带者,基因研究在确诊β地中海贫血特征诊断中的作用,并检测重型β地中海贫血患儿亲属中的基因缺陷。
对109名年龄在6个月至18岁之间的健康儿童进行了横断面研究,这些儿童是重型β地中海贫血病例的亲属(二级和四级亲属)。
使用扩增阻滞突变系统(ARMS)聚合酶链反应(PCR)进行基因筛查,涵盖了地中海地区最常见的22个等位基因,除了重型β地中海贫血患儿亲属中β地中海贫血携带者的高患病率(34.8%)外,还成功检测出了研究参与者中61.5%的β珠蛋白链突变。
发现重型β地中海贫血患儿亲属中的β地中海贫血携带者率非常高。尽管基因筛查在检测β地中海贫血携带者方面具有准确性,但使用最常见的22个等位基因只能检测出61.5%的携带者;因此,在检测携带者率方面,所检测基因研究的价值仍然有限。